{
  "attach_pages": "5",
  "attach_size": "332",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201908281345215542_1.pdf?1566990471000.pdf",
  "company_code": "80000134",
  "eitime": "2019-08-28 11:07:51",
  "extend": {},
  "info_code": "AP201908281345215542",
  "language": "0",
  "notice_date": "2019-08-28 00:00:00",
  "notice_title": "Q2经营环比改善显著，看好公司仿制药持续放量",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "BBB",
  "researcher": "周新明,李伟",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "465",
          "publishName": "化学制药"
        }
      ],
      "short_name": "科伦药业",
      "short_name_ch": "科伦药业",
      "short_name_cht": "科倫藥業",
      "short_name_en": "KELUN PHARMA",
      "stock": "002422"
    }
  ],
  "short_name": "科伦药业",
  "source_sample_name": "华金证券",
  "star": "1"
}